PATENT CLAIM ANALYSIS

Application Number: 15861234
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-05
Patent Classification: ["514", "024000"]

Abstract:
The invention provides for the use of pharmaceutical compositions comprising a thiazolide in the stimulation of the immune system in a subject in need thereof, thereby preventing and/or treating viral diseases, cancer and diseases caused by intracellular protozoan infections

Claim (Index 15):
The method of  claim 1 , wherein said administering stimulates T helper cell or CTL activity, TLR7 or TLR8 expression or type I interferon response in the subject.

Metadata:
- Claim Count in Document: 50.0
- Percentile: 86.0
- Lexical Diversity: 1.24242
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15525658', '12626848', '13058113', '14658409', '14070420']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7125245661381931
- 35 USC 102 Novelty (BERT): 0.5253263201963706
- Combined Prediction Score: 0.693804741544011
- Mean Citation Score: 215.573616
- Max Citation Score: 263.55383
- Similarity Product: 154.33576103826348

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test